Unicycive Therapeutics, Inc. UNCY

4.70 (0.11) (2.29%) as of 25 Sep
Market cap
$134.0M
P/E
0.0×
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

— — — —
EV/Sales
— — — —
EV/FCF
— — — —
Current Ratio
3.83 2.59 2.40 3.81
Net Debt/EBITDA
5.93 5.84 6.65 6.13
Debt/Equity
0.00 0.00 0.00 0.00
Free Cash Flow Yield
— — — —
Free Cash Flow per Share
(0.33) (0.51) (0.26) (0.28)
Book value per Share
2.07 1.90 1.58 1.98
Free Cash Flow
(5.96) (8.03) (6.25) (7.60)
EV/EBIT
— — — —
Other line items

Show all line items

Columns are period end dates